罗亚-ROCK2信号传递在癌症进展中具有复杂的病理生理功能,并显示出有前途的治疗潜力
Yidi Ning1, Minying Zheng2, Yue Zhang3
1Nankai University School of Medicine, Nankai University, Tianjin, 300071, P.R. China.
Cancer cell international
|October 14, 2024
概括
通过促进细胞分裂缺陷,RhoA/ROCK2通路驱动癌症的进展,转移和治疗耐药性. 抑制RhoA/ROCK2可能提供新的癌症治疗策略.
科学领域:
- 细胞生物学 细胞生物学
- 分子瘤学分子瘤学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 这种Rho GTPase信号通路调节了基本的细胞过程,如actin组织,运动性和基因转录.
- 罗亚及其效应器ROCK2与癌症的进展有关,包括上皮细胞-介质细胞过渡,入侵和癌症干细胞的治疗抵抗.
研究的目的:
- 审查RhoA/ROCK2信号传导在癌症进展机制中的作用.
- 总结RhoA/ROCK2抑制剂作为潜在的治疗策略,防止癌症复发和转移.
主要方法:
- 文献综述侧重于癌症中的RhoA/ROCK2信号传递.
- 分析研究,研究Rho信号传递,细胞分裂和癌症干细胞特性之间的联系.
- 关于现有和潜在的RhoA/ROCK2抑制剂的数据汇编.
主要成果:
- 罗亚/ROCK2信号传递对于癌细胞迁移,入侵和治疗耐药性的发展至关重要.
- 由Rho信号介导的线粒细胞缺陷和细胞动能失败有助于多倍体化,促进瘤复发和转移.
- 准RhoA/ROCK2信号传导是克服治疗耐药性的有希望的途径.
结论:
- 罗亚/ROCK2信号传递在推动癌症进展和治疗挑战方面发挥着重要作用.
- 向RhoA/ROCK2通路的抑制剂有可能改善癌症治疗策略和预防复发.
更多相关视频
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
3.6K
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
